0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Cytotoxic Drug Resistance Mechanisms (Paperback, Softcover reprint of hardcover 1st ed. 1999) Loot Price: R3,469
Discovery Miles 34 690
Cytotoxic Drug Resistance Mechanisms (Paperback, Softcover reprint of hardcover 1st ed. 1999): Robert Brown, Uta Boeger-Brown

Cytotoxic Drug Resistance Mechanisms (Paperback, Softcover reprint of hardcover 1st ed. 1999)

Robert Brown, Uta Boeger-Brown

Series: Methods in Molecular Medicine, 28

 (sign in to rate)
Loot Price R3,469 Discovery Miles 34 690 | Repayment Terms: R325 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

There is now a range of cytotoxic drugs that have considerable clinical usefulness in producing responses in tumors and even, in a small proportion of cases, cure. However, the acquisition of drug resistance is a major clinical problem and is perhaps the main limiting factor in successful treatment of cancer. Thus, a tumor initially sensitive to chemotherapy will, in the majority of cases, eventually recur as a resistant tumor, which will then progress. Much of our understanding of drug resistance mechanisms comes from the study of tumor cell lines grown in tissue culture. We now understand many of the - lecular mechanisms that can lead to a cell acquiring resistance to antic- cer drugs; however, we still do not know which mechanism(s) are those most relevant to the problem of clinical drug resistance. Indeed, given that many of the cytotoxic anticancer drugs were discovered by random screening, it is - clear what features give a clinically useful anticancer drug a sufficient the- peutic index to be of value. The aim of Cytotoxic Drug Resistance Mechanisms is to provide pro- cols that are appropriate for examining the mechanisms of cellular resistance to anticancer cytotoxics in human tumor samples. Tumor cell lines have been enormously useful as experimental models of drug resistance mechanisms, however they have limitations and we need to address the relevance of such mechanisms in patients' tumors. Examining drug resistance in tumors is much more problematic than in cell lines.

General

Imprint: HumanaPress
Country of origin: United States
Series: Methods in Molecular Medicine, 28
Release date: November 2010
First published: 1999
Editors: Robert Brown • Uta Boeger-Brown
Dimensions: 229 x 152 x 14mm (L x W x T)
Format: Paperback
Pages: 238
Edition: Softcover reprint of hardcover 1st ed. 1999
ISBN-13: 978-1-61737-093-9
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-61737-093-2
Barcode: 9781617370939

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners